BR112014020213A2 - biomarcadores para o diagnóstico, o prognóstico, a avaliação e a estratificação de terapia de síncope - Google Patents
biomarcadores para o diagnóstico, o prognóstico, a avaliação e a estratificação de terapia de síncopeInfo
- Publication number
- BR112014020213A2 BR112014020213A2 BR112014020213A BR112014020213A BR112014020213A2 BR 112014020213 A2 BR112014020213 A2 BR 112014020213A2 BR 112014020213 A BR112014020213 A BR 112014020213A BR 112014020213 A BR112014020213 A BR 112014020213A BR 112014020213 A2 BR112014020213 A2 BR 112014020213A2
- Authority
- BR
- Brazil
- Prior art keywords
- stratification
- prognosis
- diagnosis
- evaluation
- biomarkers
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/322—Orthostatic hypertension or syncope
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Abstract
resumo patente de invenção: "biomarcadores para o diagnóstico, o prognóstico, a avaliação e a estratificação de terapia de síncope". a presente invenção refere-se a um processo para o diagnóstico e/ou o prognóstico e/ou a avaliação e/ou a estratificação de terapia de síncope em um paciente o processo compreendendo: a determinação do nível de pelo menos um biomarcador selecionado do grupo que consiste em proet-1, proadm, proanp, probnp, proavp e pct ou um fragmento de pelo menos 12 aminoácidos do mesmo, em uma amostra de um fluido corporal do dito paciente, a correlação do dito nível de pelo menos um biomarcador ou fragmentos do mesmo com o diagnóstico e/ou o prognóstico e/ou a avaliação e/ou a estratificação de terapia de síncope.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20120002935 EP2657707A1 (en) | 2012-04-26 | 2012-04-26 | Biomakers for the diagnosis, prognosis, assessment and therapy stratification syncope |
PCT/EP2013/001081 WO2013159872A1 (en) | 2012-04-26 | 2013-04-12 | Biomarkers for the diagnosis, prognosis, assessment and therapy stratification of syncope |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014020213A2 true BR112014020213A2 (pt) | 2017-07-04 |
Family
ID=48142720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014020213A BR112014020213A2 (pt) | 2012-04-26 | 2013-04-12 | biomarcadores para o diagnóstico, o prognóstico, a avaliação e a estratificação de terapia de síncope |
Country Status (7)
Country | Link |
---|---|
US (1) | US20150119271A1 (pt) |
EP (2) | EP2657707A1 (pt) |
JP (1) | JP6062532B2 (pt) |
CN (1) | CN104115012B (pt) |
BR (1) | BR112014020213A2 (pt) |
RU (1) | RU2613885C2 (pt) |
WO (1) | WO2013159872A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2648385C (en) | 2006-04-04 | 2020-09-01 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
US7838250B1 (en) | 2006-04-04 | 2010-11-23 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
WO2010144358A1 (en) | 2009-06-08 | 2010-12-16 | Singulex, Inc. | Highly sensitive biomarker panels |
WO2014116708A1 (en) * | 2013-01-22 | 2014-07-31 | Singulex, Inc. | Endothelin in the diagnosis of cardiac disease |
AU2017230706A1 (en) * | 2016-03-09 | 2018-09-27 | Biomerica, Inc. | Compositions, devices, and methods of functional dyspepsia sensitivity testing |
AU2017235312A1 (en) * | 2016-03-15 | 2018-10-04 | Biomerica, Inc. | Compositions, devices, and methods of fibromyalgia sensitivity testing |
US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
CN117275737B (zh) * | 2023-11-22 | 2024-02-23 | 首都医科大学宣武医院 | 一种直立性低血压智能诊疗方法、设备及可存储介质 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5993811A (en) * | 1997-02-03 | 1999-11-30 | Biology Associates, Llc | Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
CN1339466A (zh) * | 2000-08-21 | 2002-03-13 | 上海博德基因开发有限公司 | 一种新的多肽——人内皮素受体b相似蛋白23.65和编码这种多肽的多核苷酸 |
DE10316583A1 (de) * | 2003-04-10 | 2004-10-28 | B.R.A.H.M.S Aktiengesellschaft | Bestimmung eines midregionalen Proadrenomedullin-Teilpeptids in biologischen Flüssigkeiten zu diagnostischen Zwecken, sowie Immunoassays für die Durchführung einer solchen Bestimmung |
US20060099608A1 (en) * | 2004-03-29 | 2006-05-11 | Medstar Research Institute | Methods of diagnosing cardiovascular disease |
JP5757873B2 (ja) * | 2008-10-31 | 2015-08-05 | ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 代謝症候群、心血管疾患及び/又はインスリン耐性に関連する障害の診断、予後、モニターリング及び治療追跡のためのインビトロ方法 |
EP2427764B1 (en) * | 2009-05-05 | 2017-07-26 | B.R.A.H.M.S GmbH | Vasoactive hormone-based stratification of patients suffering from diseases related to endothelial function/dysfunction |
RU2409310C1 (ru) * | 2009-10-26 | 2011-01-20 | Федеральное государственное учреждение "Государственный научно-исследовательский центр профилактической медицины Федерального агентства по высокотехнологичной медицинской помощи" | Способ диагностики ортостатической гипотензии |
-
2012
- 2012-04-26 EP EP20120002935 patent/EP2657707A1/en not_active Withdrawn
-
2013
- 2013-04-12 CN CN201380009967.XA patent/CN104115012B/zh active Active
- 2013-04-12 US US14/396,793 patent/US20150119271A1/en not_active Abandoned
- 2013-04-12 BR BR112014020213A patent/BR112014020213A2/pt not_active Application Discontinuation
- 2013-04-12 EP EP13717432.2A patent/EP2841949B1/en active Active
- 2013-04-12 WO PCT/EP2013/001081 patent/WO2013159872A1/en active Application Filing
- 2013-04-12 RU RU2014136453A patent/RU2613885C2/ru active
- 2013-04-12 JP JP2015507406A patent/JP6062532B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2015519550A (ja) | 2015-07-09 |
CN104115012A (zh) | 2014-10-22 |
RU2613885C2 (ru) | 2017-03-21 |
EP2657707A1 (en) | 2013-10-30 |
EP2841949A1 (en) | 2015-03-04 |
WO2013159872A8 (en) | 2014-08-07 |
EP2841949B1 (en) | 2017-11-22 |
CN104115012B (zh) | 2016-02-10 |
WO2013159872A1 (en) | 2013-10-31 |
RU2014136453A (ru) | 2016-06-20 |
JP6062532B2 (ja) | 2017-01-18 |
US20150119271A1 (en) | 2015-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014020213A2 (pt) | biomarcadores para o diagnóstico, o prognóstico, a avaliação e a estratificação de terapia de síncope | |
BR112013030606A2 (pt) | biomarcadores para terapia inibidora de hedgehog | |
BR112012008665A2 (pt) | tratamento de câncer | |
BR112014021897A2 (pt) | nova fusão fgfr3 | |
MX2018012580A (es) | Métodos y kits para el diagnóstico y la estratificación de riesgo en pacientes con isquemia. | |
MX2018008421A (es) | Métodos para tratar cáncer y el uso de biomarcadores como predictor de sensibilidad clínica a terapias. | |
BR112014031365A2 (pt) | métodos de detectar doenças ou condições | |
NZ593514A (en) | p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer | |
EA201890169A1 (ru) | Тау-связывающие антитела | |
WO2014193999A3 (en) | Biomarker methods and compositions | |
BR112013003391A2 (pt) | biomarcadores de câncer pancreático e usos dos mesmos | |
BRPI1007321A2 (pt) | métodos para medir e/ou quantificar a presença e/ou quantidade de her-3 ou her-3 em um complexo em uma amostra de um paciente, e para determinar se um indivíduo com um câncer é provável de responder ao tratamento com uma terapia alvejada, e, anticorpo. | |
BR112014012101A2 (pt) | métodos de tratamento de artrite psoriática (psa) usando os antagonistas de il- 17 e alelos de resposta ou não resposta à psa | |
AR084831A1 (es) | Terapia anticancer mediante inhibidores de quinasa | |
BR112013023540A2 (pt) | anticorpo, kit e método para a determinação de peptídeos amilóides | |
MX366653B (es) | Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal. | |
EA201400117A1 (ru) | Способы и нуклеиновые кислоты для определения прогноза у больных раком | |
BR112012009262A2 (pt) | ''método para inibir a proliferação de células de câncer positivo para ar em um indivíduo diagnosticado com,ou qual se suspeita que tenha cânce positivo para ar e método para identificar se um indivíduo é um candidato para tratamento com uma composiçâo | |
BR112016002845A2 (pt) | composições e métodos para tratar condições associadas ao complemento | |
BR112013010918A2 (pt) | sal de alumínio contendo elevada percentagem de al30 | |
MX2016016742A (es) | Ceramidas y su uso en el diagnostico de enfermedad cardiovascular (ecv). | |
BR112017005554A2 (pt) | métodos para predizer o risco de um sujeito progredir rapidamente para insuficiência cardíaca crônica e usos de pelo menos um biomarcador e de pelo menos um agente de ligação | |
BR112017025995A2 (pt) | inibidor de igfbp3, composição farmacêutica para uso no tratamento e/ou prevenção de um distúrbio intestinal, método para o diagnóstico de um distúrbio intestinal em um indivíduo e kit para o diagnóstico de um distúrbio intestinal | |
BR112014009223A8 (pt) | método para o diagnóstico da doença de niemann-pick | |
BR112013030473A2 (pt) | meios e métodos para diagnóstico e tratamento de esclerose múltipla |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |